Woodland Hills, CA, United States of America

Dennis J Slamon

USPTO Granted Patents = 23 

 

Average Co-Inventor Count = 3.0

ph-index = 11

Forward Citations = 741(Granted Patents)


Location History:

  • Woodland Hills, CA (US) (1987 - 2011)
  • Los Angeles, CA (US) (2023 - 2024)

Company Filing History:


Years Active: 1987-2025

Loading Chart...
Loading Chart...
23 patents (USPTO):

Title: The Innovative Work of Dennis J. Slamon

Introduction

Dennis J. Slamon is an esteemed inventor located in Woodland Hills, CA, known for his significant contributions in the field of cancer research and antibody development. With a remarkable portfolio of 19 patents, Slamon's work has paved the way for new therapeutic options in oncology.

Latest Patents

Among his latest patents are innovations regarding Claudin-6 antibodies and drug conjugates. This work provides antigen-binding proteins that target Claudin-6 (CLDN6), specifically binding to the Extracellular Loop 2 (EL2) of its extracellular domain. The patent encompasses related polypeptides, nucleic acids, vectors, host cells, and conjugates, along with methods for creating these proteins and treating subjects with cancer. Another significant patent focuses on Claudin-18 antibodies and methods for cancer treatment. This disclosure includes antigen-binding proteins that target Claudin-18.2 (CLDN18.2), bispecific proteins that bind to CLDN18.2 and another antigen, and additional related compositions.

Career Highlights

Slamon has made notable advancements while working at the University of California and Sugen Incorporated. His innovative research and developments in antibody therapeutics have had a profound impact on treatment methodologies for cancer, providing both hope and tangible advancements in medical science.

Collaborations

Throughout his career, Slamon has collaborated with several accomplished professionals, including Klaus Peter Hirth and Donna Pruess Schwartz. These collaborations have further enriched his research and fostered significant developments in the field of biomedicine.

Conclusion

In conclusion, Dennis J. Slamon's contributions to the field of cancer research through his numerous patents highlight his status as a leading inventor. His work not only expands the boundaries of scientific knowledge but also plays a crucial role in advancing treatment options for patients with cancer. His innovative spirit and collaborative efforts ensure a lasting impact in the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…